Altamira Therapeutics Ltd. Other Finance Cost
Altamira Therapeutics Ltd. (CYTOF) reported Other Finance Cost of $37.31 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OtherFinanceCost · last filed 2025-08-29
CHF
| Period end | Other Finance Cost 6 month | Other Finance Cost 12 month | Other Finance Cost 12 month as first filed |
|---|---|---|---|
| 2023-12-31 | 1.67M CHF 20-F/A · filed 2024-04-22 | ||
| 2022-12-31 | 1.21M CHF 20-F/A · filed 2024-04-22 | 1.14K CHF 20-F · filed 2023-05-16 | |
| 2022-06-30 | 1.14K CHF 6-K · filed 2023-09-12 | ||
| 2021-12-31 | 14.11K CHF 20-F/A · filed 2024-04-22 | ||
| 2020-12-31 | 219.62K CHF 20-F · filed 2023-05-16 |
USD
| Period end | Other Finance Cost 6 month | Other Finance Cost 12 month |
|---|---|---|
| 2025-06-30 | $37.31K 6-K · filed 2025-08-29 | |
| 2024-12-31 | $836.79K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $186.00K 6-K · filed 2025-08-29 | |
| 2023-12-31 | $1.86M 20-F · filed 2025-04-30 | |
| 2022-12-31 | $1.27M 20-F · filed 2025-04-30 |